By Gina Shaw
Las Vegas—Oncology, oncology, oncology.
That’s arguably the major focus of the behemoth 13th annual EMD Serono Specialty Digest report, released Monday, May 1 at the Asembia Specialty Pharmacy Summit 2017. Oncology tops nearly every list for the 58 commercial health plans surveyed, representing some 173 million lives—a response level up slightly from last year, noted Kevin Host, PharmD, the president and chief operating officer of Pharmaceutical Strategies group,